Collect Product
Product Details
Background
Recombinant Monoclonal Anti-CD20 Antibody, Mouse (6C8) is a CD20 primary antibody for IHC application. CD20 is expressed on the surface of B cells at all stages of development and differentiation except plasma cells (B cells secreting immunoglobulin). It directly acts on B cells by regulating transmembrane calcium ion flow and plays an important regulatory role in the proliferation and differentiation of B cells.
Product Specifications
Host SpeciesMouseIsotypeMouse IgGClone6C8ApplicationIHC-PDilution Ratio1: 200 - 1: 1000FormLiquidClonalityMonoclonalReactivityHumanSynonymsBp35, Leu-16Concentration0.9~1.1 mg/mlSpecificityReact with CD20 protein on the membrane of target cell/tissuePurification TechProtein APreservationTris buffer, 1% BSAExperiment Protocol
Storage
Shipped at 4°C, Blue Ice. Store at +4°C for short term (1-2 weeks). Store at -20°C for long term.
Avoid freeze / thaw cycle. Upon delivery aliquot.ACRO Quality Management System
Kunden haben auch angesehen
Data Display
Sample Staining Data
Immunohistochemical analysis of paraffin embedded human cancer tissue labelled with HGS-S241 at 1:500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
User Reviews Publish Comment
Frontier Progress
Drug Development Progress- English Name：
B-lymphocyte antigen CD20
- Category：
- Listed Drugs Count：
35 Details
- Clinical Drugs Count：
132 Details
- Highest R&D Stage：
Approved
Contact Us
Drug Candidate Licensing